Novartis
NVS
876 hedge funds and large institutions have $17.3B invested in Novartis in 2016 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 335 increasing their positions, 345 reducing their positions, and 103 closing their positions.
0.17% more ownership
Funds ownership: 9.78% → 9.94% (+0.17%)
1% less call options, than puts
Call options by funds: $32.3M | Put options by funds: $32.7M
3% less repeat investments, than reductions
Existing positions increased: 335 | Existing positions reduced: 345
6% less funds holding
Funds holding: 927 → 876 (-51)
13% less capital invested
Capital invested by funds: $20B → $17.3B (-$2.65B)
39% less first-time investments, than exits
New positions opened: 63 | Existing positions closed: 103
50% less funds holding in top 10
Funds holding in top 10: 42 → 21 (-21)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$167M |
| 2 |
BBHC
Brown Brothers Harriman & Co
New York
|
+$69.5M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$68.3M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$66.6M |
| 5 |
CI
Cambiar Investors
Denver,
Colorado
|
+$59.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WI
WHV Investments
San Francisco,
California
|
-$81.3M |
| 2 |
IC
Institutional Capital
Chicago,
Illinois
|
-$60.6M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$41.9M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$31M |
| 5 |
State Street
Boston,
Massachusetts
|
-$24.1M |
NVS Hedge Fund Activity: Q1 2016 in Review
876 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q1 2016, worth a combined $17.3B — down 13% from $20B a quarter earlier.
Sellers outnumbered buyers: 103 funds closed out of NVS and 63 opened new positions — a net loss of 40 holders — while 345 trimmed existing stakes and 335 added.
The largest buyer was Franklin Resources, adding an estimated $167M. The largest seller was WHV Investments, cutting an estimated $81.3M.
- 876 institutional investors held Novartis (NVS) as of Q1 2016, down from 927 in Q4 2015.
- Funds reported $17.3B of Novartis stock for Q1 2016, down 13% quarter-over-quarter.
- 63 funds opened new Novartis positions in Q1 2016 and 103 closed out, a net change of -40 holders.
- The largest Novartis buyer in Q1 2016 was Franklin Resources, an estimated $167M added.
- The largest Novartis seller in Q1 2016 was WHV Investments, an estimated $81.3M sold.
Based on aggregated 13F filings for Q1 2016.